EVM
AZN icon

Eaton Vance Management’s AstraZeneca AZN Stock Holding History

Eaton Vance Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$80.2M Sell
731,482
-116
-0% -$14.7K 0.12% 173
2022
Q2 		$96.7M Sell
731,598
-4,940
-0.7% -$648K 0.14% 156
2022
Q1 		$97.7M Buy
736,538
+617
+0.1% +$74K 0.11% 182
2021
Q4 		$85.7M Buy
735,921
+14,427
+2% +$1.7M 0.1% 194
2021
Q3 		$86M Buy
721,494
+605,143
+520% +$70.4M 0.12% 173
2021
Q2 		$13.9M Sell
116,351
-3,149
-3% -$345K 0.02% 532
2021
Q1 		$11.9M Buy
119,500
+228
+0.2% +$22.9K 0.02% 534
2020
Q4 		$11.9M Buy
119,272
+1,915
+2% +$203K 0.02% 504
2020
Q3 		$12.9M Sell
117,357
-602
-0.5% -$67K 0.02% 438
2020
Q2 		$12.5M Sell
117,959
-91,252
-44% -$9.42M 0.03% 411
2020
Q1 		$18.7M Sell
209,211
-164,341
-44% -$15.5M 0.05% 307
2019
Q4 		$37.3M Sell
373,552
-12,155
-3% -$1.14M 0.07% 235
2019
Q3 		$34.4M Buy
385,707
+104,047
+37% +$9.02M 0.07% 232
2019
Q2 		$23.3M Buy
281,660
+64,781
+30% +$5.08M 0.05% 283
2019
Q1 		$17.5M Buy
+216,879
New +$17.1M 0.04% 309

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Eaton Vance Management's AZN Position: Q3 2022 in Review

Eaton Vance Management reduced its AstraZeneca (AZN) stake by 0.02% in Q3 2022, selling an estimated $14.7K and leaving 731,482 shares worth $80.2M. The position accounts for 0.12% of the portfolio, ranked #173.

Eaton Vance Management first reported a position in AZN in Q1 2019 and has held it in 15 quarters since. The position peaked at $97.7M in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Eaton Vance Management held 731,482 shares of AstraZeneca worth $80.2M as of Q3 2022.
  • Eaton Vance Management sold 116 AstraZeneca shares in Q3 2022, an estimated $14.7K.
  • AstraZeneca made up 0.12% of Eaton Vance Management's portfolio in Q3 2022, its #173 holding.
  • Eaton Vance Management first reported a position in AstraZeneca in Q1 2019 and has held it in 15 quarters since.
  • Eaton Vance Management's AstraZeneca position peaked at $97.7M in Q1 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.